Ovarian cancer and malignancies of the uterine cervix and corpus are the most commonly encountered gynecologic neoplasms in clinical practice. Although of little value in both diagnosis and early-stage gynecologic malignancy, fluorodeoxyglucose-PET and PET/computed tomography provide accurate detection of metastatic disease in advanced malignancy and better delineation of recurrent disease compared with conventional imaging.